Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison

OBJECTIVE: Matching-adjusted indirect comparison was used to assess the comparative effectiveness of secukinumab 150 mg and adalimumab 40 mg in biologic-naïve patients with ankylosing spondylitis (AS) for up to 1 year. METHODS: Pooled individual patient data from the secukinumab arms of MEASURE 1 (N...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Rheumatol
Main Authors: Maksymowych, Walter P., Strand, Vibeke, Nash, Peter, Yazici, Yusuf, Thom, Howard, Hunger, Matthias, Kalyvas, Chrysostomos, Gandhi, Kunal K., Porter, Brian, Jugl, Steffen M.
Formato: Artigo
Idioma:Inglês
Publicado em: Medical Research and Education Association 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6267743/
https://ncbi.nlm.nih.gov/pubmed/30388073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2018.18162
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados